| Literature DB >> 33591464 |
Aurora Ninfa1,2, Nicole Pizzorni3, Angelo Eplite1, Claudia Moltisanti1, Antonio Schindler1.
Abstract
The Functional Oral Intake Scale (FOIS) is a reliable and valid tool to assess functional oral intake of food and liquids in patients with oropharyngeal dysphagia (OD). Its validity was established for stroke patients against Videofluoroscopic Swallowing Study in English and Chinese and against Fiberoptic Endoscopic Evaluation of Swallowing (FEES) in German. FOIS was cross-culturally validated into Italian (FOIS-It), but construct validity against instrumental assessment and nutritional status was not investigated. The study aims at contributing to the validation of the FOIS-It, by performing convergent and known-group validity against FEES and nutritional status in patients with OD of different etiologies. Overall, 220 adult patients with OD of etiological heterogeneity were recruited. FOIS-It score and Body Mass Index (BMI) were collected. FEES was performed to assess swallowing safety and efficiency based on the Penetration-Aspiration Scale (PAS) and the Yale Pharyngeal Residue Severity Rating Scale (YPRSRS). Moderate to weak associations with PAS (ρ = - .37, p < .01), YPRSRS in the pyriform sinuses (ρ = - .20, p < .01), and BMI (ρ = .24, p < .01) were detected with Spearman's correlation. FOIS-It distribution was compared with the Mann-Whitney U and Kruskal-Wallis tests. Significantly lower FOIS-It scores were detected among patients with penetration/aspiration (PAS > 2) and penetration (PAS > 2 ≤ 5) for all consistencies (p < .01), aspiration (PAS > 5) of liquids and semisolids (p < .001), residue in the pyriform sinuses (YPRSRS > 3) with semisolids (p < .001) and solids (p = .02), and malnutrition (BMI ≤ 18.5; p = .019). FOIS-It appears as a valid tool to assess functional oral intake against FEES' measures of swallowing safety and efficiency and nutritional status in patients with OD of etiological heterogeneity.Entities:
Keywords: Deglutition; Deglutition disorders; Fiberoptic endoscopic evaluation of swallowing; Functional oral intake; Nutritional status; Validation
Mesh:
Year: 2021 PMID: 33591464 PMCID: PMC8844182 DOI: 10.1007/s00455-021-10257-9
Source DB: PubMed Journal: Dysphagia ISSN: 0179-051X Impact factor: 3.438
Demographic and clinical characteristics of the recruited patients
| Variable | Mean ± SD or |
|---|---|
| Age | |
| Years | 65.2 ± 13.5 |
| Gender | |
| M | 120 (54.5) |
| F | 100 (45.5) |
| Diagnosis | |
| Huntington disease | 59 (26.8) |
| Amyotrophic lateral sclerosis | 48 (21.8) |
| Parkinson’s disease/Parkinsonism | 29 (13.2) |
| Stroke | 23 (10.5) |
| Head and neck cancer | 18 (8.2) |
| Multiple system atrophy | 9 (4.1) |
| Steinert myotonic dystrophy | 6 (2.7) |
| Brain tumor | 4 (1.8) |
| Othersa | 24 (10.9) |
aAlzheimer’s Disease; Aneurysm; Obstructive Chronic Bronchopneumopathy; Corticobasal Degeneration; Dermatomyositis; Zenker’s Diverticulum; Giullan-Barré Syndrome; Cardiac surgery; Cerebral hypoxia; Gastric Tumor; Systemic Sclerosis; Myopathy; Extrapyramidal Disorder; Syringomyelia; Traumatic Brain Injury; Cerebral Vasculitis
Fig. 1FOIS-It distribution
Fig. 2Correlation between FOIS-It and PAS worst score. The line of best fit with 95% confidence interval is displayed. The legend reports the number of patients corresponding to each dot dimension
Spearman’s correlation coefficients (ρ) between FOIS-It and PAS and YPRSRS in the Valleculae and Pyriform sinuses
| Consistency | PAS | YPRSRS valleculae | YPRSRS pyriform sinuses |
|---|---|---|---|
| Liquids | − .35** | .017 | − .04 |
| Semisolids | − .23** | − .14* | − .24** |
| Solids | − .26** | − .09 | − .27** |
| Worst score | − .37** | − .10 | − .20** |
*p < .05; **p < .01
Results of the Mann–Whitney U and Kruskal–Wallis tests for the comparison of FOIS-It between patients with and without penetration/aspiration (PAS > 2), penetration (PAS > 2 ≤ 5), and aspiration (PAS > 5) on FEES
| Bolus type | Sign of dysphagia | FOIS-It | |||
|---|---|---|---|---|---|
| N | Median (IQR) | Mann–Whitney U/Kruskal–Wallis test | |||
| Liquids | Penetration/aspiration | ||||
| PAS ≤ 2 | 67 | 6.0 (5.0–7.0) | 3193.000 | ||
| PAS > 2 | 152 | 5.0 (4.0–6.0) | |||
| Penetration | |||||
| PAS ≤ 2 | 67 | 6.0 (5.0–7.0) | 25.477 | ||
| PAS > 2 ≤ 5 | 86 | 5.0 (4.0–6.0) | |||
| PAS > 5 | 66 | 4.5 (3.0–6.0) | |||
| Aspiration | |||||
| PAS ≤ 5 | 153 | 6.0 (5.0–7.0) | 3350.500 | ||
| PAS > 5 | 66 | 4.5 (3.0–6.0) | |||
| Semisolids | Penetration/aspiration | ||||
| PAS ≤ 2 | 142 | 6.0 (5.0–7.0) | 3798.000 | ||
| PAS > 2 | 75 | 5.0 (4.0–6.0) | |||
| Penetration | |||||
| PAS ≤ 2 | 142 | 6.0 (5.0–7.0) | 18.784 | ||
| PAS > 2 ≤ 5 | 58 | 5.0 (4.0–6.0) | |||
| PAS > 5 | 17 | 4.0 (2.0–5.0) | |||
| Aspiration | |||||
| PAS ≤ 5 | 200 | 5.0 (4.0–6.0) | 799.500 | ||
| PAS > 5 | 17 | 4.0 (2.0–5.0) | |||
| Solids | Penetration/aspiration | ||||
| PAS ≤ 2 | 146 | 6.0 (5.0–7.0) | 871.500 | ||
| PAS > 2 | 22 | 4.5 (3.0–6.0) | |||
| Penetration | |||||
| PAS ≤ 2 | 146 | 6.0 (5.0–7.0) | 12.913 | ||
| PAS > 2 ≤ 5 | 17 | 5.0 (3.5–6.0) | |||
| PAS > 5 | 5 | 4.0 (1.0–6.0) | |||
| Aspiration | |||||
| PAS ≤ 5 | 163 | 6.0 (5.0–7.0) | 205.000 | .051 | |
| PAS > 5 | 5 | 4.0 (1.0–6.0) | |||
| Worst score | Penetration/aspiration | ||||
| PAS ≤ 2 | 61 | 6.0 (5.0–7.0) | 2810.000 | ||
| PAS > 2 | 158 | 5.0 (4.0–6.0) | |||
| Penetration | |||||
| PAS ≤ 2 | 61 | 6.0 (5.0–7.0) | 29.309 | ||
| PAS > 2 ≤ 5 | 89 | 5.0 (4.0–6.0) | |||
| PAS > 5 | 69 | 5.0 (3.0–6.0) | |||
| Aspiration | |||||
| PAS ≤ 5 | 150 | 6.0 (5.0–7.0) | 3393.500 | ||
| PAS > 5 | 69 | 5.0 (3.0–6.0) | |||
Statistically significant p are reported in bold
Fig. 3Correlation between FOIS-It and YPRSRS Pyriform sinus worst score. The line of best fit with 95% confidence interval is displayed. The legend reports the number of patients corresponding to each dot dimension
Fig. 4Correlation between FOIS-It and YPRSRS Valleculae worst score. The line of best fit with 95% confidence interval is displayed. The legend reports the number of patients corresponding to each dot dimension
Results of the Mann–Whitney U test for the comparison of FOIS-It between patients with and without residue (YPRSRS > 3) on FEES
| Bolus type | Sign of dysphagia | FOIS-It | |||
|---|---|---|---|---|---|
| Median (IQR) | Mann–Whitney U test | ||||
| Liquids | Residue valleculae | ||||
| Present | 11 | 5.0 (4.0–6.0) | 963.500 | .368 | |
| Absent | 208 | 5.0 (4.0–6.0) | |||
| Residue pyriform sinus | |||||
| Present | 22 | 5.0 (4.0–6.0) | 1899.500 | .332 | |
| Absent | 197 | 5.0 (4.0–6.0) | |||
| Semisolids | Residue valleculae | ||||
| Present | 69 | 5.0 (4.0–6.0) | 4171.000 | ||
| Absent | 148 | 5.0 (4.25–6.0) | |||
| Residue pyriform sinus | |||||
| Present | 47 | 4.0 (3.0–6.0) | 2486.000 | ||
| Absent | 170 | 6.0 (5.0–6.25) | |||
| Solids | Residue valleculae | ||||
| Present | 44 | 5.0 (5.0–6.0) | 2329.500 | .137 | |
| Absent | 124 | 6.0 (5.0–7.0) | |||
| Residue pyriform sinus | |||||
| Present | 14 | 5.0 (4.0–6.0) | 690.500 | ||
| Absent | 154 | 6.0 (5.0–7.0) | |||
| Worst score | Residue valleculae | ||||
| Present | 90 | 5.0 (4.0–6.0) | 4841.000 | ||
| Absent | 129 | 5.0 (4.0–7.0) | |||
| Residue pyriform sinus | |||||
| Present | 62 | 4.0 (4.0–6.0) | 3102.500 | ||
| Absent | 157 | 6.0 (5.0–7.0) | |||
Statistically significant p are reported in bold
Fig. 5Correlation between FOIS-It and BMI. The line of best fit with 95% confidence interval is displayed. The legend reports the number of patients corresponding to each dot dimension